ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry, computational, and clinical pharmacology support to Clywedog Therapeutics ...
Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference ...
FX-909, the first small molecule targeting PPARG to be tested in humans, showed monotherapy activity in advanced urothelial carcinoma with a ...
Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ova ...
Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced initial results from the ongoing Phase 1 ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV ...
On a chilly April morning, Travis Gienger took his first gamble of the 2025 season. The world-champion giant-pumpkin grower ...
IIT Kharagpur is exploring alternate routes for offering admission to its B.Tech and B.S. programmes. Read the full story to ...
The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory diseases ...
In vertebrates, calcium is stored in bones, and its release is tightly regulated. Now, using fruit flies as a model organism, researchers at University of Tsukuba have shown that even animals without ...